Thermo Fisher Scientific Inc
Thermo Fisher Scientific is a U.S.-based life sciences and laboratory company organized around four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. It supplies instruments, consumables, diagnostics, and outsourced services used in research, clinical testing, and biopharmaceutical development and manufacturing across global markets.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueReagents, instruments, and workflow tools used in biological research and drug discovery.
Instrumentation and software for measuring, analyzing, and characterizing samples.
Diagnostic assays, instruments, and related products for clinical and applied testing.
Consumables, chemicals, equipment, and procurement-channel offerings for labs.
Outsourced development, clinical research, and manufacturing services for drug makers.
Products
Reported · share of revenue- Consumables41.9 %
- Services41.7 %
- Instruments16.4 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Thermo Fisher sells to pharmaceutical and biotechnology companies, hospitals, clinical diagnostic laboratories, universities, research institutions, and government agencies. It also serves industrial, environmental, and quality-control customers that need instruments, consumables, and testing services for regulated workflows. The company’s broad customer base reflects its role as a supplier of both mission-critical lab inputs and outsourced scientific services.
Buy reagents, instruments, and outsourced development/manufacturing services to advance drug pipelines.
Buy diagnostic products and lab systems used in patient testing and clinical workflows.
Buy research tools, consumables, and analytical systems for scientific programs.
Buy analytical and quality-control products for process monitoring and compliance.
Buy integrated clinical research and pharma services for outsourced execution.
Strategy
Thermo Fisher’s strategy centers on high-impact innovation, trusted customer relationships, and a large commercial engine that can cross-sell instruments, consumables, and services. It also emphasizes R&D, geographic sales expansion, e-commerce, and operational productivity to deepen its position in scientific workflows and biopharma outsourcing.
New technologies and improved workflows help retain customers and win share in research and diagnostics.
A broad portfolio lets the company sell multiple products into the same lab or biopharma account.
Outsourced development, clinical research, and manufacturing deepen customer relationships and diversify revenue.
Operational efficiency supports competitiveness in a fragmented, price-sensitive lab market.
Geography
Q1/2026Thermo Fisher operates globally and sells through direct sales, e-commerce, and distributors across North America, Europe, Asia-Pacific, and other international markets. Its manufacturing, service, and commercial footprint is broad, which supports local customer service but also exposes the company to cross-border supply chain, regulatory, and currency risks. The business depends on global demand from life sciences, diagnostics, and industrial end markets rather than a single country or region.
Share of the revenue the company reports by geography.
Risks
Thermo Fisher faces supply-chain and sourcing risk because some products depend on sole or limited suppliers and regulated materials. It also carries legal, quality, regulatory, and cybersecurity exposure, while its broad global footprint makes it sensitive to trade restrictions, geopolitical events, and currency movements. Goodwill and acquisition-related assets are also important because the company has grown through acquisitions and must support those values with future cash flows.
- Supply chain concentration and supplier disruptionImpact: HighLikelihood: Medium
Some materials and components come from sole or limited sources, making production vulnerable to interruptions.
Exposure: Manufacturing and lab product supply chains
- Regulatory, legal, and product quality exposureImpact: HighLikelihood: Medium
Diagnostics, instruments, and pharma services operate in regulated environments where failures can create claims or delays.
Exposure: Clinical diagnostics and biopharma services
- Goodwill impairment riskImpact: HighLikelihood: Low
Acquisition-driven growth leaves a large goodwill balance that depends on future cash flow assumptions.
Exposure: Reporting units and acquired businesses
- Geopolitical and trade restriction riskImpact: MediumLikelihood: Medium
International sourcing and sales can be disrupted by sanctions, tariffs, export controls, or war.
Exposure: Global operations
- Cybersecurity and technology disruptionImpact: MediumLikelihood: Medium
A large digital and commercial footprint increases exposure to ransomware and other cyber incidents.
Exposure: Commercial systems and operations
Accounting
Judgemental itemsA large goodwill balance requires annual valuation testing and can be sensitive to discount rates and growth assumptions.
Impact: Could create non-cash impairment charges if expected cash flows weaken
The company is contingently liable for certain legal proceedings and personal injury matters.
Impact: Can affect operating expense, liabilities, and cash outflows
Acquisition-related earn-outs and similar obligations must be remeasured over time.
Impact: Can create fair value gains or losses in earnings
Management uses it to isolate underlying demand from acquisitions and currency effects.
Impact: Important for comparing reported growth to operational performance
Similar listed companies
Publicly listed companies with a comparable business focus.
Mesa Laboratories, Inc
MLAB · Industrial Instruments For Measurement, Display, and Control
Mesa Laboratories designs and manufactures life sciences tools and critical quality control solutions used in regulated pharmaceutical, healthcare, and medical device applications.
Harvard Bioscience, Inc
HBIO · Laboratory Analytical Instruments
Harvard Bioscience designs, manufactures, and sells life-science research tools used in drug discovery, translational medicine, and preclinical testing.
Waters Corporation
WAT · Laboratory Analytical Instruments
Waters Corp.
Danaher Corporation
DHR · Industrial Instruments For Measurement, Display, and Control
Danaher is a U.S.-based science and technology company organized around biotechnology, life sciences, and diagnostics.
Bruker Corporation
BRKR · Laboratory Analytical Instruments
Bruker Corp designs, manufactures, and distributes high-performance scientific instruments and analytical and diagnostic solutions used to study life and…
Scientific Industries Inc
SCND · Laboratory Analytical Instruments
Last updated: 24/09/2026